Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RP1”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Not applicableNo Longer AvailableNCT06590480
What this trial is testing

An Expanded Access Program for VO (RP1) in Combination With Nivolumab in Patients With Advanced Melanoma

Who this might be right for
Advanced Melanoma
Replimune, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT06067061
What this trial is testing

"neoBREASTIM": Atezolizumab Plus RP1 Oncolytic Immunotherapy in the NeoAdjuvant Setting of Triple-Negative Breast Cancer

Who this might be right for
Triple Negative Breast Neoplasms
Institut Curie 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT05858229
What this trial is testing

Neo-adjuvant Treatment for Squamous Cell Carcinoma Using Direct Tumor Injection With RP1.

Who this might be right for
Squamous Cell CarcinomaRP1
Sherrif Ibrahim 12
Not applicableLooking for participantsNCT06887348
What this trial is testing

Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3

Who this might be right for
MelanomaMetastatic MelanomaAdvanced Solid Tumor+1 more
Replimune, Inc. 50
Early research (Phase 1)Study completedNCT03063021
What this trial is testing

The FIGHT-RP1 Study

Who this might be right for
Retinitis Pigmentosa
Johns Hopkins University 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04050436
What this trial is testing

Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer

Who this might be right for
Cutaneous Squamous Cell CarcinomaAdvanced Cutaneous Squamous Cell CarcinomaMetastatic Cutaneous Squamous Cell Carcinoma
Replimune, Inc. 231
Post-approval studies (Phase 4)Study completedNCT04776889
What this trial is testing

The Prognosis of Lipid Reprogramming With Rosuvastatin, in Castrated Egyptian Prostate Cancer Patients

Who this might be right for
Prostate Cancer Metastatic
National Cancer Institute, Egypt 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT04349436
What this trial is testing

Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ Transplants and Advanced Skin Malignancies

Who this might be right for
Merkel Cell CarcinomaBasal Cell CarcinomaLocally Advanced Cutaneous Squamous Cell Carcinoma+1 more
Replimune, Inc. 69
Early research (Phase 1)Active Not RecruitingNCT03999021
What this trial is testing

FIGHT-RP 1 Extension Study

Who this might be right for
Retinitis Pigmentosa
Johns Hopkins University 30
Very early researchLooking for participantsNCT06216938
What this trial is testing

RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node Metastasis

Who this might be right for
Melanoma
Yana Najjar 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT03767348
What this trial is testing

Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE)

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)Microsatellite Instability-High (MSI-H)Non-melanoma Skin Cancer (NMSC)+1 more
Replimune, Inc. 340